Eisner Mark - Insider Non-Derivative Transactions at Vir Biotechnology, Inc. (VIR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 15, 2024, Eisner Mark's relationship to Vir Biotechnology, Inc. (VIR) is Officer (EVP and Chief Medical Officer), and currently has 75,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other VIR insiders.
Data Source: SEC.
Eisner Mark - Insider Non-Derivative Transactions at VIR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 16, 2024 | Acquisition -- (Common Stock) | 75000 | 0 | 75000 |